US Broker Ratings

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Leader with 8.11% Potential Upside

Exelixis, Inc. (NASDAQ: EXEL) stands as a beacon in the biotechnology sector, renowned for its focus on developing novel therapies for challenging cancer types. Headquartered in Alameda, California, Exelixis has..

Insulet Corporation (PODD) Stock Analysis: A 46.51% Potential Upside Amid Strong Revenue Growth

Investors with a keen eye on the healthcare sector might find Insulet Corporation (NASDAQ: PODD) an intriguing prospect, particularly given its robust revenue growth and the promising outlook from analysts...

Chemed Corp (CHE) Stock Analysis: Healthcare Service Leader Eyes 16.85% Potential Upside

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, is drawing investor attention with its robust service offerings and a notable potential upside of 16.85%. Headquartered in Cincinnati,..

Glaukos Corporation (GKOS) Stock Analysis: Strong Buy Ratings and a Potential 12% Upside for This Medical Device Innovator

Investors eyeing the healthcare sector might want to take a closer look at Glaukos Corporation (NYSE: GKOS), a leader in ophthalmic pharmaceuticals and medical technology. With a market capitalization of..

Mettler-Toledo International (MTD): Investor Outlook on a Healthcare Giant with 8.99% Potential Upside

Mettler-Toledo International Inc. (NYSE: MTD), a powerhouse in precision instruments within the healthcare sector, is capturing the attention of investors with its robust market position and promising prospects. Headquartered in..

Revolution Medicines (RVMD) Stock Analysis: Exploring a 19.75% Upside in the Precision Oncology Space

Revolution Medicines, Inc. (NASDAQ: RVMD) has been making waves in the biotechnology sector with its cutting-edge research in precision oncology. As a clinical-stage company focused on developing novel therapies for..

Repligen Corporation (RGEN) Stock Analysis: Growth Momentum and a 40% Upside Potential

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specializes in bioprocessing technologies and systems that cater to the life sciences industry. With a market capitalization of $7.64..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A 26% Upside Potential with Strong Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector specializing in medical instruments and supplies, is capturing investor attention with a significant upside potential and robust..

Grifols, S.A. (GRFS)

⚠️ No article content returned.

..

Tempus AI, Inc. (TEM) Stock Analysis: Uncovering a 48.56% Potential Upside in Healthcare Tech

Tempus AI, Inc. (NASDAQ: TEM) is carving a niche in the healthcare technology sector, with its innovative solutions that combine molecular testing with data analytics. Despite recent market challenges, the..

Elevance Health, Inc. (ELV) Stock Analysis: Uncovering a 13.10% Upside Potential in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, presents a compelling opportunity for investors seeking exposure to the rapidly evolving U.S. healthcare market. With a..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a 7.3% Upside Potential Amid Robust Revenue Growth

Medpace Holdings, Inc. (NASDAQ: MEDP), an established leader in clinical research-based drug and medical device development, has recently caught the attention of investors and analysts alike. With a robust market..

United Therapeutics Corporation (UTHR) Stock Analysis: Potential Upside of 13.77% Amid Robust Pipeline and Strategic Collaborations

United Therapeutics Corporation (NASDAQ: UTHR), a prominent player in the healthcare sector, is making waves with its strong focus on addressing unmet medical needs in the treatment of chronic and..

Cardinal Health, Inc. (CAH) Stock Analysis: Steady Growth and a 10% Upside Potential

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, is making waves with its compelling financial performance and promising growth trajectory. With a market capitalization of $52.81..

Avantor, Inc. (AVTR) Stock Analysis: Exploring a 20.63% Potential Upside Amidst Challenging Metrics

Avantor, Inc. (NYSE: AVTR), a prominent player in the Healthcare sector, specifically within the Medical Instruments & Supplies industry, finds itself at a critical juncture. With a market capitalization of..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Player with Robust Revenue Growth and Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) stands out as a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $12.24 billion,..

Quest Diagnostics (DGX) Stock Analysis: Strong Revenue Growth and a Promising 7.39% Potential Upside

Quest Diagnostics Incorporated (NYSE: DGX) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $22.52 billion, Quest Diagnostics..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 38.69% Potential Upside in the Biotech Sector

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading biotechnology firm headquartered in San Rafael, California, is making significant strides in the healthcare sector by pioneering therapies for rare and life-threatening diseases...

Boston Scientific Corporation (BSX) Stock Analysis: Evaluating a 40% Potential Upside with Strong Buy Ratings

Boston Scientific Corporation (NYSE: BSX), a titan in the medical device industry, presents an enticing opportunity for investors with a robust market capitalization of $110.6 billion. As a leader in..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Navigating an 11.18% Potential Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the healthcare sector, is garnering significant investor attention. With a market capitalization of $39.85 billion, Teva is a key player in the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds